ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer Meeting Abstract
| Authors: | Dent, R.; Schmid, P.; Cortes, J.; Kim, S. B.; Andre, F.; Abramson, V.; Cardoso, F.; Colleoni, M.; Morris, P.; Steinberg, J.; Tudor, I. C.; Uppal, H.; Paton, V. E.; Peterson, A.; Traina, T. A. |
| Abstract Title: | ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer |
| Meeting Title: | 2016 San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 77 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2016 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000397999000105 |
| DOI: | 10.1158/1538-7445.sabcs16-ot3-02-02 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OT3-02-02 -- Source: Wos |
